Lv11
50 积分 2025-01-08 加入
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
1小时前
已完结
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
1个月前
已完结
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
2个月前
已完结
Identification of erythropoietin mimetic peptide 1 linear form in a sealed vial and its administration study in horses for doping control purpose
2个月前
已完结
Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent
2个月前
已关闭
The transcriptional and regulatory identity of erythropoietin producing cells
2个月前
已完结
Polycystic kidney disease
2个月前
已完结
Modeling and biological evaluation of pegmolesatide, a novel and potent erythropoiesis-stimulating agent
3个月前
已完结
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
4个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
7个月前
已完结
皖公网安备34019202002308
